Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2009 May 27;52(5):459–463. doi: 10.1007/s11427-009-0059-7

Avian influenza H5N1: an update on molecular pathogenesis

HongLiang Wang 1, ChengYu Jiang 1,✉
PMCID: PMC7088835  PMID: 19471868

Abstract

Avian influenza A virus constitutes a large threat to human health. Recent outbreaks of highly pathogenic avian influenza H5N1 virus in poultry and in humans have raised concerns that an influenza pandemic will occur in the near future. Transmission from avian species to humans remains sporadic, but the mortality associated with human infection is very high (about 62%). To date, there are no effective therapeutic drugs or a prophylactic vaccines available, which means that there is still a long way to go before we can eradicate or cure avian influenza. This review focuses on the molecular pathogenesis of avian influenza H5N1 virus infection. An understanding of the viral pathogenesis may facilitate the development of novel treatments or effective eradication of this fatal disease.

Keywords: avian flu, H5N1, acute lung injury

References

  • 1.Abdel-Ghafar A. N., Chotpitayasunondh T., Gao Z., et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2008;358:261–273. doi: 10.1056/NEJMra0707279. [DOI] [PubMed] [Google Scholar]
  • 2.Hui D. S. Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection. Respirology. 2008;13(Suppl1):S10–S13. doi: 10.1111/j.1440-1843.2008.01247.x. [DOI] [PubMed] [Google Scholar]
  • 3.Thanh T. T., van Doorn H. R., de Jong M. D. Human H5N1 influenza: current insight into pathogenesis. Int J Biochem Cell Biol. 2008;40:2671–2674. doi: 10.1016/j.biocel.2008.05.019. [DOI] [PubMed] [Google Scholar]
  • 4.Gambotto A., Barratt-Boyes S. M., de Jong M. D., et al. Human infection with highly pathogenic H5N1 influenza virus. Lancet. 2008;371:1464–1475. doi: 10.1016/S0140-6736(08)60627-3. [DOI] [PubMed] [Google Scholar]
  • 5.Spackman E. A brief introduction to the avian influenza virus. Methods Mol Biol. 2008;436:1–6. doi: 10.1007/978-1-59745-279-3_1. [DOI] [PubMed] [Google Scholar]
  • 6.Horimoto T., Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol. 2005;3:591–600. doi: 10.1038/nrmicro1208. [DOI] [PubMed] [Google Scholar]
  • 7.Lewis D. B. Avian flu to human influenza. Annu Rev Med. 2006;57:139–154. doi: 10.1146/annurev.med.57.121304.131333. [DOI] [PubMed] [Google Scholar]
  • 8.Matrosovich M. N., Matrosovich T. Y., Gray T., et al. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol. 2004;78:12665–12667. doi: 10.1128/JVI.78.22.12665-12667.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Air G. M., Laver W. G. The neuraminidase of influenza virus. Proteins. 1989;6:341–356. doi: 10.1002/prot.340060402. [DOI] [PubMed] [Google Scholar]
  • 10.Seo S. H., Hoffmann E., Webster R. G. The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. Virus Res. 2004;103:107–113. doi: 10.1016/j.virusres.2004.02.022. [DOI] [PubMed] [Google Scholar]
  • 11.Allen P. J. Avian influenza pandemic: not if, but when. Pediatr Nurs. 2006;32:76–81. [PubMed] [Google Scholar]
  • 12.de Jong J. C., Claas E. C., Osterhaus A. D., et al. A pandemic warning? Nature. 1997;389:554. doi: 10.1038/39218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zambon M. C. The pathogenesis of influenza in humans. Rev Med Virol. 2001;11:227–41. doi: 10.1002/rmv.319. [DOI] [PubMed] [Google Scholar]
  • 14.Pascoe N. A pandemic flu: not if, but when. SARS was the wake-up call we slept through. Tex Nurs. 2006;80:6–10. [PubMed] [Google Scholar]
  • 15.Suzuki Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull. 2005;28:399–408. doi: 10.1248/bpb.28.399. [DOI] [PubMed] [Google Scholar]
  • 16.Rogers G. N., Paulson J. C. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology. 1983;127:361–373. doi: 10.1016/0042-6822(83)90150-2. [DOI] [PubMed] [Google Scholar]
  • 17.Ito T., Couceiro J. N., Kelm S., et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol. 1998;72:7367–7373. doi: 10.1128/jvi.72.9.7367-7373.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Cyranoski D. Bird flu spreads among Java’s pigs. Nature. 2005;435:390–391. doi: 10.1038/435390a. [DOI] [PubMed] [Google Scholar]
  • 19.Ma W. J. REKaJAR. The pig as a mixing vessel for influenza viruses: Human and veterinary implications. J Mol Genet Med. 2009;3:158–166. doi: 10.4172/1747-0862.1000028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nicholls J. M., Chan R. W., Russell R. J., et al. Evolving complexities of influenza virus and its receptors. Trends Microbiol. 2008;16:149–157. doi: 10.1016/j.tim.2008.01.008. [DOI] [PubMed] [Google Scholar]
  • 21.Guo Y., Rumschlag-Booms E., Wang J., et al. Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza. Virol J. 2009;6:39. doi: 10.1186/1743-422X-6-39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nicholls J. M., Peiris J. S. Avian influenza: update on pathogenesis and laboratory diagnosis. Respirology. 2008;13(Suppl1):S14–18. doi: 10.1111/j.1440-1843.2008.01248.x. [DOI] [PubMed] [Google Scholar]
  • 23.de Jong M. D., Bach V. C., Phan T. Q., et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 2005;352:686–691. doi: 10.1056/NEJMoa044307. [DOI] [PubMed] [Google Scholar]
  • 24.Abrahams A. H. N., French H. A further investigation into influenzo-pneumococcoal septicaemia: epidemic influenzal ‘pneumonic’ of highly fatal type and its relation to purulent bronchitis. lancet. 1919;196:1–11. doi: 10.1016/S0140-6736(01)22115-1. [DOI] [Google Scholar]
  • 25.Johnson N. P., Mueller J. Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull Hist Med. 2002;76:105–115. doi: 10.1353/bhm.2002.0022. [DOI] [PubMed] [Google Scholar]
  • 26.Imai Y., Kuba K., Neely G. G., et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133:235–249. doi: 10.1016/j.cell.2008.02.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Akira S., Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499–511. doi: 10.1038/nri1391. [DOI] [PubMed] [Google Scholar]
  • 28.Miller Y. I., Viriyakosol S., Binder C. J., et al. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem. 2003;278:1561–1568. doi: 10.1074/jbc.M209634200. [DOI] [PubMed] [Google Scholar]
  • 29.Tang P. S., Mura M., Seth R., et al. Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol. 2008;294:L632–641. doi: 10.1152/ajplung.00262.2007. [DOI] [PubMed] [Google Scholar]
  • 30.Martin T. R., Hagimoto N., Nakamura M., et al. Apoptosis and epithelial injury in the lungs. Proc Am Thorac Soc. 2005;2:214–220. doi: 10.1513/pats.200504-031AC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Uiprasertkul M., Kitphati R., Puthavathana P., et al. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis. 2007;13:708–712. doi: 10.3201/eid1305.060572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Tumpey T. M., Lu X., Morken T., et al. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol. 2000;74:6105–6116. doi: 10.1128/JVI.74.13.6105-6116.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Li C, L H, Sun Y, et al. Nanoparticle Starburst polyamidoamine dendrimers promote acute lung injury by inducing autophagic cell death through Akt-TSC2-mTOR signaling pathway. J Mol Cell Biol (in press) [DOI] [PubMed]
  • 34.Kuba K., Imai Y., Rao S., et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875–879. doi: 10.1038/nm1267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wang H., Rao S., Jiang C. Molecular pathogenesis of severe acute respiratory syndrome. Microbes Infect. 2007;9:119–126. doi: 10.1016/j.micinf.2006.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Science in China. Series C, Life Sciences are provided here courtesy of Nature Publishing Group

RESOURCES